Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 4 min ago
Peer-reviewedCC BYJournal of Nanobiotechnology

Magnetic field-controlled nanozymes effectively overcome therapeutic limitations in tumor ferroptosis therapy

  1. 1Department of Orthopedics, Movement System Injury and Repair Research Center, Xiangya Hospital, Central South University

Abstract

Iron oxide nanozymes with intrinsic peroxidase-like activity and excellent biosafety are considered ideal agents for inducing tumor ferroptosis. However, their practical catalytic efficiency is often constrained by an inherent delocalized electronic structure and the restrictive tumor antioxidant microenvironment. Herein, we report a magnetic field-mediated strategy to synthesize ultra-small superparamagnetic manganese-doped iron oxide (USMIO) nanoparticles with precisely tailored multi-enzyme activities (denoted as MUSMIO). The magnetic field in situ generated abundant oxygen vacancies and optimized the Mn/Fe coordination environment, significantly boosting electron transfer and catalytic performance. MUSMIO exhibited robust pH-responsive peroxidase-like activity with a hydroxyl radical yield ∼5.86-fold higher than pure ultra-small superparamagnetic iron oxide (USIO) and ∼2.43-fold higher than USMIO, together with favorable catalase-, glutathione oxidase-, and nicotinamide adenine dinucleotide phosphate oxidase-like activities. This synergistic multi-enzyme cascade efficiently blocked glutathione regeneration, relieved tumor hypoxia, and triggered a sustained hydroxyl radical storm to drive extensive lipid peroxidation and selective ferroptosis in cancer cells, while exhibiting negligible toxicity to normal cells. In a murine breast cancer model, MUSMIO achieved complete tumor regression with no recurrence, and prolonged the median survival time of mice with excellent biosafety. This work provides a generalizable physical-field-assisted route for designing high-performance multi-enzyme mimetic nanozymes for targeted tumor therapy. Graphical Abstract

Related

  1. Frustrated Lewis Pair‐Induced Pre‐Adsorbed Oxygen Coupled With Reactant Availability as a Design Strategy for High‐Performance Single‐Atom Nanozymes
    Yanjun Ji, Wenhao Miao, Lin Cheng +7
    Angewandte Chemie International EditionPeer-reviewedLicence not stated6 citedMaterials & polymersOpenAlex
  2. Self-assembling peptide hydrogel SPG-178 effectively prevents postoperative pancreatic fistula compared with polyglycolic acid mesh with fibrin glue in rats
    Takeshi Kado, Yoshito Tomimaru, Hirofumi Akita +14
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMaterials & polymersCrossref
  3. Self-adaptive nanozymes with enhanced multi-enzyme activities for sequential multimodal therapy of drug-resistant bacteria-infected wounds
    Xiaoyong Zhang, Hang Yu, Kai Zhu +10
    Nature CommunicationsPeer-reviewedCC BY10 citedMaterials & polymersOpenAlex
  4. Copper‐Doped Prussian Blue Nanozymes With Hyaluronic Acid‐Mediated Targeting Alleviate Oxidative Stress and Regulate Cholesterol Handling for Atherosclerosis Therapy
    Jianliang Ou, Ruihua Ji, Qinglu Zang +12
    Advanced SciencePeer-reviewedCC BY 4.0Full text1 citedMaterials & polymersPMC
  5. Bio-dissociable platinum quantum dot cluster nanozymes for nonhormonal endometriosis therapy through microenvironment remodeling
    Cheng Cao, Jie Ding, Huifang Hao +10
    Materials Today BioPeer-reviewedCC BY 4.0Full textMaterials & polymersDOAJPMC
BibTeX
@article{hu2026magnetic,
  title = {{Magnetic field-controlled nanozymes effectively overcome therapeutic limitations in tumor ferroptosis therapy}},
  author = {Xin-Yue Hu and Xiao-Yan Tang and Cong Liu and Xiao-Xiao Gong and Shan-Shan Rao and Chun-Yuan Chen and Zhen-Xing Wang and Hui Xie and Hong-Ji Liu},
  journal = {Journal of Nanobiotechnology},
  year = {2026},
  month = jul,
  doi = {10.1186/s12951-026-04796-2},
  url = {https://doi.org/10.1186/s12951-026-04796-2},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Magnetic field-controlled nanozymes effectively overcome therapeutic limitations in tumor ferroptosis therapy
AU  - Xin-Yue Hu
AU  - Xiao-Yan Tang
AU  - Cong Liu
AU  - Xiao-Xiao Gong
AU  - Shan-Shan Rao
AU  - Chun-Yuan Chen
AU  - Zhen-Xing Wang
AU  - Hui Xie
AU  - Hong-Ji Liu
PY  - 2026
DA  - 2026/07/01
JO  - Journal of Nanobiotechnology
DO  - 10.1186/s12951-026-04796-2
UR  - https://doi.org/10.1186/s12951-026-04796-2
AB  - Iron oxide nanozymes with intrinsic peroxidase-like activity and excellent biosafety are considered ideal agents for inducing tumor ferroptosis. However, their practical catalytic efficiency is often constrained by an inherent delocalized electronic structure and the restrictive tumor antioxidant microenvironment. Herein, we report a magnetic field-mediated strategy to synthesize ultra-small superparamagnetic manganese-doped iron oxide (USMIO) nanoparticles with precisely tailored multi-enzyme activities (denoted as MUSMIO). The magnetic field in situ generated abundant oxygen vacancies and optimized the Mn/Fe coordination environment, significantly boosting electron transfer and catalytic performance. MUSMIO exhibited robust pH-responsive peroxidase-like activity with a hydroxyl radical yield ∼5.86-fold higher than pure ultra-small superparamagnetic iron oxide (USIO) and ∼2.43-fold higher than USMIO, together with favorable catalase-, glutathione oxidase-, and nicotinamide adenine dinucleotide phosphate oxidase-like activities. This synergistic multi-enzyme cascade efficiently blocked glutathione regeneration, relieved tumor hypoxia, and triggered a sustained hydroxyl radical storm to drive extensive lipid peroxidation and selective ferroptosis in cancer cells, while exhibiting negligible toxicity to normal cells. In a murine breast cancer model, MUSMIO achieved complete tumor regression with no recurrence, and prolonged the median survival time of mice with excellent biosafety. This work provides a generalizable physical-field-assisted route for designing high-performance multi-enzyme mimetic nanozymes for targeted tumor therapy. Graphical Abstract
SN  - 1477-3155
ER  -